Antimicrobial peptides as promising drugs for treatment of primary viral pneumonia
The COVID-19 pandemic which began in March 2020 has again drawn attention to the problem of treating primary viral pneumonia (PVP), wherein damage to the tissues of the lower respiratory tract including functionally important alveolocytes occurs as a result of cell infection by pathogens of the Vira...
Enregistré dans:
Auteurs principaux: | M. Yu. Shchelkanov, A. V. Cybulsky, V. G. Dedkov, I. V. Galkina, V. V. Maleev |
---|---|
Format: | article |
Langue: | RU |
Publié: |
Sankt-Peterburg : NIIÈM imeni Pastera
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/edfbbf9c547a4ae99b487a065c38211f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
MUCOSAL MICROFLORA AND INNATE IMMUNITY OF UPPER RESPIRATORY TRACT IN INTRAUTERINE FOETAL INFECTION AND PNEUMONIA OF NEONATES
par: O. A. Svitich, et autres
Publié: (2016) -
ASSOCIATION OF TLR2, TLR4, TLR9 GENE EXPRESSION RELATED TO INNATE IMMUNITY WITH IN VIVO ACUTE RESPIRATORY INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE
par: E. V. Budanova, et autres
Publié: (2018) -
Etiología viral en la neumonía del adulto adquirida en la comunidad en un hospital del sur de Chile
par: Rioseco Z,M. Luisa, et autres
Publié: (2012) -
Post‐coronavirus disease 2019 organizing pneumonia confirmed pathologically by video‐assisted thoracoscopic surgery
par: Keishi Sugino, et autres
Publié: (2021) -
Differential Diagnosis between Coronavirus Disease 2019 and Interstitial Pneumonia
par: PENG Min, et autres
Publié: (2020)